References
- Cross D. M. Isolated hepatocytes as a model for ranitidine metabolism: in vivo and in vitro correlations in the rat, dog and guinea-pig. University of Hertfordshire. 1991, PhD thesis
- Cross D. M., Bell J. A., Wilson K. Kinetics of ranitidine metabolism in dog and rat isolated hepatocytes. Xenobiotica 1995; 25: 367–375
- Davies B., Morris T. Physiological parameters in laboratory animals and humans. Pharmaceutical Research 1993; 10: 1093–1095
- Garg C., Weidler D. J., Eshelman F. N. Ranitidine bioavailability and kinetics in normal male subjects. Clinical Pharmacology and Therapeutics 1983; 33: 445–452
- Jenner W. N., Martin L. E., Willoughby B. A., Fellows I. The development of a radioimmunoassay for ranitidine in biological fluids. Life Sciences 1981; 28: 1323–1329
- Manchee G. R., Bell J. A., Broom C., Lant M. S., Oxford J. M. The metabolism and excretion of [3H]-ranitidine in man. Abstracts of the European Drug Metabolism Workshop, Guildford, England. Taylor and Francis, Basingstoke 1986, No. P1/13
- Martin L. E., Bell J. A., Carey P. F., Dallas F. A. A., Dixon G. T., Jenner W. N. A review of pharmacokinetics and metabolism of ranitidine in animals and man. The Clinical Use of Ranitidine. Medicine Publ. Foundation, Oxford 1982; 23–31
- Mitchard M., McIsaac R. L., Bell J. A. H2-receptor antagonists. Sulphur-Containing Drugs and Related Organic Compounds, vol. 3, Part A: Metabolism and Pharmacokinetics of Sulphur-Containing Drugs, L. A. Damani. Ellis Horwood, chichester 1989; 53–86
- Suttle B., Brouwer K. L. R. Contribution of enterohepatic recirculation to ranitidine pharmacokinetics in rats. Pharmacology Research 1991; 8: 259
- Suttle B., Brouwer K. L. R. Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat. Drug Metabolism and Disposition 1994; 22: 224–232
- Varughese A., Lee C.S. C. Disposition kinetics of ranitidine in rats. Drugs in Experimental and Clinical Research 1983; IX: 837–842
- Zeldis J. B., Friedman L. S., Isselbacher K. J. Ranitidine: a new H2-receptor antagonist. New England Journal of Medicine 1983; 309: 1368–1373